Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,471,436
-
Share change
-
+985,613
-
Total reported value
-
$83,927,000
-
Price per share
-
$4.10
-
Number of holders
-
66
-
Value change
-
+$2,170,364
-
Number of buys
-
37
-
Number of sells
-
26
Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q4 2017
As of 31 Dec 2017,
ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,471,436 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BVF INC/IL, PERCEPTIVE ADVISORS LLC, Vanguard Group Inc, AMERIPRISE FINANCIAL INC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Alyeska Investment Group, L.P., ADAMS STREET PARTNERS LLC, and Candriam Luxembourg S.C.A..
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.